feed,title,long_url,short_url
🔐MarketWatch,Neumora Therapeutics initiated with overweight rating and $21 price target at J.P. Morgan,http://www.marketwatch.com/tools/quotes/quotes.asp?symb=NMRA&siteid=rss,https://da.gd/EUIU
